Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension

por Tomomitsu Kanaya, Shigeru Miyagawa, Takuji Kawamura, Yoshiki Sakai, Kenta Masada, Nobutoshi Nawa, Hidekazu Ishida, Jun Narita, Koichi Toda, Toru Kuratani, Yoshiki Sawa
Publicado 2021